A Case of Gemcitabine and Cisplatin Associated Posterior Reversible Encephalopathy Syndrome
Eun Jin Kwon, Se Won Kim, Kwang Ki Kim, Hyung Suk Seo, Do Yeun Kim
Cancer Res Treat. 2009;41(1):53-55.   Published online 2009 Mar 31     DOI: https://doi.org/10.4143/crt.2009.41.1.53
Citations to this article as recorded by Crossref logo
Newly identified adverse events for gemcitabine using the Food and Drug Administration Adverse Event Reporting System
Wei Zhang, Yuhong Wang, Xin Jiang, Hu Zhao, Xinli Jia, Qiye Wang, Yue Chen, Yuanfang Jiang, Zhifang Ma, Lina Chang, Xin Wang
Expert Opinion on Drug Safety.2023; : 1.     CrossRef
Posterior reversible encephalopathy syndrome in pregnancy: A case series of 5 cases
Vaibhavi Birle, Pradnya Dongargaonkar, Sunil Sharma, AditiSandip Gaiwal
MGM Journal of Medical Sciences.2022; 9(2): 246.     CrossRef
Delayed Gemcitabine-Induced Posterior Reversible Encephalopathy Syndrome
John R. Schaub, Shou-Ching Tang
The American Journal of the Medical Sciences.2021; 361(6): 795.     CrossRef
Delayed Posterior Reversible Leukoencephalopathy Syndrome Triggered by FLOT Chemotherapy
Jordi Gandini, Mario Manto, Nicolas Charette
Frontiers in Neurology.2020;[Epub]     CrossRef
First line Immunotherapy for Non-Small Cell Lung Cancer
Nicola J. Nasser, Miguel Gorenberg, Abed Agbarya
Pharmaceuticals.2020; 13(11): 373.     CrossRef
Prognostic factors and seizure outcome in posterior reversible encephalopathy syndrome (PRES) in children with hematological malignancies and bone marrow failure: A retrospective monocentric study
Pavlína Danhofer, Michaela Tomečková, Dáša Černá, Danica Zapletalová, Ondřej Horák, Štefánia Aulická, Lenka Juříková, Jiří Domanský, Petra Kovalčíková, Tomáš Pavlík, Jaroslav Štěrba, Hana Ošlejšková
Seizure.2019; 72: 1.     CrossRef
PRES in the course of hemato-oncological treatment in children
Katarzyna Musioł, Sylwia Waz, Michał Boroń, Magdalena Kwiatek, Magdalena Machnikowska-Sokołowska, Katarzyna Gruszczyńska, Grażyna Sobol-Milejska
Child's Nervous System.2018; 34(4): 691.     CrossRef
Posterior reversible encephalopathy syndrome (PRES) in mesenteric leiomyosarcoma: A case report
Ramy Schoucair, Gregory Nicolas, Rechdi Ahdab, Noha Bejjani, Eddie K. Abdalla
International Journal of Surgery Case Reports.2018; 49: 96.     CrossRef
Posterior Reversible Encephalopathy Syndrome in a Patient with Spinal Metastasis
Jin Wook Kim, Ju Ho Jeong
Journal of Neurointensive Care.2018; 1(1): 47.     CrossRef
Electrographic patterns in patients with posterior reversible encephalopathy syndrome and seizures
Carlos Kamiya-Matsuoka, Sudhakar Tummala
Journal of the Neurological Sciences.2017; 375: 294.     CrossRef
A case report of posterior reversible encephalopathy syndrome in a patient receiving gemcitabine and cisplatin
Hannah Cherniawsky, Neesha Merchant, Micheal Sawyer, Maria Ho
Medicine.2017; 96(8): e5850.     CrossRef
Neurological PRESentations in Sickle Cell Patients Are Not Always Stroke: A Review of Posterior Reversible Encephalopathy Syndrome in Sickle Cell Disease
Ziad Solh, Michael S. Taccone, Samantha Marin, Uma Athale, Vicky R. Breakey
Pediatric Blood & Cancer.2016; 63(6): 983.     CrossRef
Posterior reversible encephalopathy syndrome in cancer patients: a single institution retrospective study
Carlos Kamiya-Matsuoka, Asif M. Paker, Linda Chi, Ayda Youssef, Sudhakar Tummala, Monica E. Loghin
Journal of Neuro-Oncology.2016; 128(1): 75.     CrossRef
Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome
Joan How, Margaret Blattner, Susan Fowler, Andrea Wang-Gillam, Suzanne E. Schindler
The Neurologist.2016; 21(6): 112.     CrossRef
Reversible posterior leukoencephalopathy syndrome following combinatorial cisplatin and pemetrexed therapy for lung cancer in a normotensive patient: A case report and literature review
CHANGQING XIE, VOVANTI T. JONES
Oncology Letters.2016; 11(2): 1512.     CrossRef
A Unique Case of Rituximab-Related Posterior Reversible Encephalopathy Syndrome in a Heart Transplant Recipient With Posttransplant Lymphoproliferative Disorder
A. Jaiswal, I. Sabnani, D.A. Baran, M.J. Zucker
American Journal of Transplantation.2015; 15(3): 823.     CrossRef
Posterior Reversible Encephalopathy Syndrome: A Neurologic Phenomenon in Cancer Patients
Eileen M. Le, Monica E. Loghin
Current Oncology Reports.2014;[Epub]     CrossRef
Acute neurological disorders following intraperitoneal administration of cisplatin
Geert A.A.M. Simkens, Monique C.J. Hanse, Ignace H.J.T. de Hingh
International Journal of Gynecology & Obstetrics.2013; 120(3): 291.     CrossRef
Gemcitabine-induced posterior reversible encephalopathy syndrome: A case report
Pasquale Cioffi, Lucio Laudadio, Antonio Nuzzo, Maurizio Belfiglio, Fabio Petrelli, Iolanda Grappasonni
Journal of Oncology Pharmacy Practice.2012; 18(2): 299.     CrossRef
Posterior Reversible Encephalopathy Syndrome During Ipilimumab Therapy for Malignant Melanoma
Michela Maur, Chiara Tomasello, Antonio Frassoldati, Maria Vittoria Dieci, Elena Barbieri, PierFranco Conte
Journal of Clinical Oncology.2012; 30(6): e76.     CrossRef
Reversible Posterior Leukoencephalopathy Syndrome following Sunitinib Therapy: A Case Report and Review of the Literature
Khurum H Khan, Audrey Fenton, Eimer Murtagh, James JA McAleer, Alison Clayton
Tumori Journal.2012; 98(5): e139.     CrossRef
Des pathologies encéphaliques à connaître — Syndrome d’encéphalopathie postérieure réversible
S. Legriel, F. Pico, F. Bruneel, G. Troché, J. -P. Bedos
Réanimation.2011; 20(S2): 368.     CrossRef
Acute Transverse Myelopathy Probably Related to Intravenous Gemcitabine Plus Cisplatin
Meizuo Zhong, Bin Li, Jing Li
Annals of Pharmacotherapy.2011; 45(4): 544.     CrossRef
Case Files of the New York City Poison Control Center: Paradichlorobenzene-Induced Leukoencephalopathy
Stephanie H. Hernandez, Sage W. Wiener, Silas W. Smith
Journal of Medical Toxicology.2010; 6(2): 217.     CrossRef